HuGE Literature Finder
Records
1
-
14
A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma. Cancer cell international 2020 6 20 207. Ouyang Guoqing, Yi Bin, Pan Guangdong, Chen Xia |
AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity. Molecular oncology 2018 1 12 (3): 373-390. Meng Yue, Wang Lu, Xu Jianjun, Zhang Qingy |
LAPTM4B*2 allele is associated with the development of papillary thyroid carcinoma in Chinese women. Oncology letters 2017 Sep 14 (3): 3421-3428. Meng Yue, Zhou Rouli, Xu Jianjun, Zhang Qingy |
Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Jun 39 (6): 1010428317705518. Wang Bing, Wang Shan, Liang Guowei, Xu Jianjun, Zhou Rouli, Zhang Qingy |
Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population. Medical oncology (Northwood, London, England) 2013 Mar 30 (1): 1. Wang B, Xu J, Zhou R, Zhang Q |
LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals 2013 Jan . Meng F, Li H, Zhou R, Luo C, Hu Y, Lou G |
Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients. Medical oncology (Northwood, London, England) 2012 Dec 29 (4): 2809-13. Yang Hua, Zhai Guojun, Ji Xiaoxu, Xiong Fuxia, Su Jing, McNutt Michael |
Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients. Medical oncology (Northwood, London, England) 2012 Dec 29 (4): 2744-9. Zhai Guojun, Yang Hua, Ji Xiaoxu, Xiong Fuxia, Su Jing, McNutt Michael A, Li Xu |
Relationship between LAPTM4B gene polymorphism and susceptibility of primary liver cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012 Jul 23 (7): 1864-9. Wang S, Zhang Q-Y, Zhou R |
LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma. PloS one 2012 7 (4): e34984. Yang Hua, Zhai Guojun, Ji Xiaoxu, Xiong Fuxia, Su Jing, McNutt Michael |
LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinoma. PloS one 2012 7 (9): e45290. Zhai Guojun, Yan Kaowen, Ji Xiaoxu, Xu Wenrui, Yang Jiuling, Xiong Fuxia, Su Jing, McNutt Michael A, Yang H |
Correlation of LAPTM4B polymorphisms with cervical carcinoma. Cancer 2011 Jun 117 (12): 2652-8. Meng Fanling, Song Hongtao, Luo Chang, Yin Mingzhu, Xu Ye, Liu Haixia, Zhou Rouli, Lou |
Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008 Mar 19 (3): 527-32. Cheng X-J, Xu W, Zhang Q-Y, Zhou R |
Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007 Feb 18 (2): 311-6. Liu Y, Zhang Q-Y, Qian N, Zhou R |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 30, 2023
- Content source: